4-amino-1-β-D-arabinofuranosyl-2(1H)-pyrimidinone
GPTKB entity
Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:administeredBy |
intravenous injection
|
| gptkbp:affiliatedWith |
nucleoside analogues
|
| gptkbp:ATCCode |
L01BC01
|
| gptkbp:CASNumber |
147-94-4
|
| gptkbp:discoveredBy |
1960s
|
| gptkbp:hasMolecularFormula |
C9H13N3O5
|
| gptkbp:hasSMILES |
C1=NC(=NC(=O)N1)N[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O
|
| gptkbp:hasUNII |
04079A1RDZ
|
| https://www.w3.org/2000/01/rdf-schema#label |
4-amino-1-β-D-arabinofuranosyl-2(1H)-pyrimidinone
|
| gptkbp:IUPACName |
gptkb:4-amino-1-β-D-arabinofuranosyl-2(1H)-pyrimidinone
|
| gptkbp:meltingPoint |
212-214°C
|
| gptkbp:PubChem_CID |
6017
6253 |
| gptkbp:synonym |
gptkb:Ara-C
Cytarabine |
| gptkbp:usedFor |
gptkb:acute_myeloid_leukemia
antineoplastic agent |
| gptkbp:bfsParent |
gptkb:cytarabine
|
| gptkbp:bfsLayer |
7
|